Skip to content

A prospective real-world study of perioperative safety management in hysteroscopic surgery based on precise monitoring of irrigation fluid absorption and bleeding

A prospective real-world study of perioperative safety management in hysteroscopic surgery based on precise monitoring of irrigation fluid absorption and bleeding

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500095545
Enrollment
Unknown
Registered
2025-01-08
Start date
2025-01-15
Completion date
Unknown
Last updated
2025-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing hysteroscopic surgery

Interventions

Observation group:None

Sponsors

Lanzhou University Second Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients will undergo hysteroscopic surgery that includes at least one of these procedures: (1) Severe intrauterine adhesion dissection; (2) Type II submucosal fibroids and intermural endomyomectomy; (3) Type I submucosal myomectomy with a diameter of >=5cm; (4) multiple submucosal myomectomy; (5) Endometrial resection.

Exclusion criteria

Exclusion criteria: (1) Patients who cannot tolerate surgery due to severe cardiopulmonary insufficiency, liver and kidney insufficiency, abnormal coagulation function, etc.; (2) Severe reproductive system infection; (3) Preoperative pathological examination showed malignant lesions; (4) Refusal to participate in the study.

Design outcomes

Primary

MeasureTime frame
Absorption amount of flushing solution;Bleeding volume;Hemoglobin;Hematocrit ;Platelet;White blood cell;Red blood cell;Potassium ion;Sodium ions;Chloride ion;Heart rate;Blood pressure;Activated partial prothrombin time;Fibrinogen content;Thrombin time;Prothrombin time;International standardized ratio;D-Dimer;

Secondary

MeasureTime frame
Neutrophil percentage;

Countries

China

Contacts

Public ContactZhiping Wang

Lanzhou University Second Hospital

erywzp@lzu.edu.cn+86 138 9313 1697

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026